WallStSmart

Cognex Corporation (CGNX)vsCoherent Inc (COHR)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Coherent Inc generates 531% more annual revenue ($6.60B vs $1.05B). CGNX leads profitability with a 13.6% profit margin vs 7.1%. COHR appears more attractively valued with a PEG of 0.92. CGNX earns a higher WallStSmart Score of 58/100 (C).

CGNX

Buy

58

out of 100

Grade: C

Growth: 6.7Profit: 6.5Value: 4.7Quality: 9.0
Piotroski: 5/9Altman Z: 3.05

COHR

Buy

56

out of 100

Grade: C

Growth: 7.3Profit: 5.0Value: 5.0Quality: 7.5
Piotroski: 5/9Altman Z: 1.53
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

CGNXUndervalued (+48.5%)

Margin of Safety

+48.5%

Fair Value

$83.47

Current Price

$60.82

$22.65 discount

UndervaluedFair: $83.47Overvalued

Intrinsic value data unavailable for COHR.

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

CGNX5 strengths · Avg: 9.2/10
EPS GrowthGrowth
122.3%10/10

Earnings expanding 122.3% YoY

Debt/EquityHealth
0.0510/10

Conservative balance sheet, low leverage

Altman Z-ScoreHealth
3.0510/10

Safe zone — low bankruptcy risk

Operating MarginProfitability
22.3%8/10

Strong operational efficiency at 22.3%

Revenue GrowthGrowth
24.3%8/10

Revenue surging 24.3% year-over-year

COHR4 strengths · Avg: 8.8/10
EPS GrowthGrowth
73.0%10/10

Earnings expanding 73.0% YoY

Market CapQuality
$83.52B9/10

Large-cap with strong market position

PEG RatioValuation
0.928/10

Growing faster than its price suggests

Revenue GrowthGrowth
20.5%8/10

Revenue surging 20.5% year-over-year

Areas to Watch

CGNX2 concerns · Avg: 2.0/10
PEG RatioValuation
2.712/10

Expensive relative to growth rate

P/E RatioValuation
74.8x2/10

Premium valuation, high expectations priced in

COHR4 concerns · Avg: 3.0/10
Altman Z-ScoreHealth
1.534/10

Distress zone — elevated risk

Return on EquityProfitability
4.4%3/10

ROE of 4.4% — below average capital efficiency

Profit MarginProfitability
7.1%3/10

7.1% margin — thin

P/E RatioValuation
204.3x2/10

Premium valuation, high expectations priced in

Comparative Analysis Report

WallStSmart Research

Bull Case : CGNX

The strongest argument for CGNX centers on EPS Growth, Debt/Equity, Altman Z-Score. Revenue growth of 24.3% demonstrates continued momentum.

Bull Case : COHR

The strongest argument for COHR centers on EPS Growth, Market Cap, PEG Ratio. Revenue growth of 20.5% demonstrates continued momentum. PEG of 0.92 suggests the stock is reasonably priced for its growth.

Bear Case : CGNX

The primary concerns for CGNX are PEG Ratio, P/E Ratio. A P/E of 74.8x leaves little room for execution misses.

Bear Case : COHR

The primary concerns for COHR are Altman Z-Score, Return on Equity, Profit Margin. A P/E of 204.3x leaves little room for execution misses.

Key Dynamics to Monitor

COHR carries more volatility with a beta of 2.05 — expect wider price swings.

CGNX is growing revenue faster at 24.3% — sustainability is the question.

CGNX generates stronger free cash flow (42M), providing more financial flexibility.

Monitor SCIENTIFIC & TECHNICAL INSTRUMENTS industry trends, competitive dynamics, and regulatory changes.

Bottom Line

CGNX scores higher overall (58/100 vs 56/100) and 24.3% revenue growth. Both earn "Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Cognex Corporation

TECHNOLOGY · SCIENTIFIC & TECHNICAL INSTRUMENTS · USA

Cognex Corporation offers machine vision products that capture and analyze visual information to automate manufacturing and distribution tasks globally. The company is headquartered in Natick, Massachusetts.

Visit Website →

Coherent Inc

TECHNOLOGY · SCIENTIFIC & TECHNICAL INSTRUMENTS · USA

Coherent, Inc. provides lasers, laser-based technologies, and laser-based system solutions for a variety of scientific, commercial, and industrial research applications. The company is headquartered in Santa Clara, California.

Want to dig deeper into these stocks?